John Koconis Net Worth & Insider Trades
John Koconis - CEO & Chairman, Timber Pharmaceuticals, Inc
What is John Koconis's Net Worth?
The current estimated net worth of Timber Pharmaceuticals, Inc's CEO & Chairman, John Koconis, is estimated to be about $46.9K . John Koconis owns about 20,000 units of Timber Pharmaceuticals, Inc common stock. In the last 3 years at Timber Pharmaceuticals, Inc, John Koconis has sold an estimated value of $0 worth.
What is John Koconis's Past Insider Trading?
John Koconis's largest purchase order was 20,000 units , worth over $7.69K on December 16, 2021. In total, John Koconis has made about 5 transactions over 3 years of their time at Timber Pharmaceuticals, Inc. John Koconis usually trades in April, with the busiest year in 2021.
John Koconis
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was John Koconis's Salary in 2020?
As CEO & Chairman of Timber Pharmaceuticals, Inc, John Koconis has a total base salary of $288,846 . John Koconis received compensation valued at about $507,264 in 2020 after becoming CEO & Chairman. The vast majority of their compensation came in the form of a bonus of $140,577 , other compensation of $77,841 .
What is John Koconis's' Mailing Address?
- Mailing address is C/o Timber Pharmaceuticals, Inc. 900 E. Hamilton Avenue, Suite 100 Campbell CA 95008 CA
Timber Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| John Koconis, | 2020 | $288,846 | $140,577 | - | $77,841 | $507,264 |
| John Koconis, | 2019 | $79,488 | $50,000 | - | $150,343 | $279,831 |
| Joseph Lucchese, | 2020 | $176,807 | $42,000 | $89,321 | $52,991 | $361,119 |
| Joseph Lucchese, | 2019 | - | - | - | - | - |
| Zachary Rome | 2020 | $183,928 | $42,000 | - | $74,742 | $300,670 |
| Zachary Rome | 2019 | $93,750 | $33,750 | - | $67,669 | $195,169 |
| Michael Derby, | 2020 | $134,077 | $42,000 | - | $37,751 | $213,828 |
| Michael Derby, | 2019 | - | - | - | - | - |
| Steven Bosacki, | 2020 | $126,215 | - | - | $45,769 | $171,984 |
| Steven Bosacki, | 2019 | $163,094 | - | $21,777 | - | $184,871 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1504167/000110465921054549/tm2113757-1_def14a.htm
What are Timber Pharmaceuticals, Inc's Past Insider Trades?
Timber Pharmaceuticals, Inc's most recent insider trade came on December 16, 2021 by John Koconis who bought 20,000 units worth $7.69K . In the last year, insiders at Timber Pharmaceuticals, Inc have sold an estimated value of $2.32M and bought an estimated value of $28.47K worth of shares. Insider trading is most common in April, with the busiest year in 2021. The most active traders at the company are Tardimed Sciences Llc, Edward Sitar, Director, and Alan Mendelsohn, EVP & CMO .
Timber Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||